Human subjects immunized with Advax-adjuvanted trivalent inactivated influenza vaccine demonstrated an enhanced day 7 post-immunization plasmablast response, with the plasmablasts showing greater frequency of non-silent mutations in the B-cell-receptor CDR3 sequence together with higher levels of activation-induced cytidine deaminase [37]. This evidence concerns the gene CDA and influenza.